Publications

Differences in presentation and management patterns in patients with hepatocellular carcinoma (HCC): Data from HCC registry in Asia. Pierce K. H. Chow, Lequn Li, Jiangtao Li, Fan Jia, Hee-Jee Wang, Kiyoshi Hasegawa, Jin-Mo Yang, Poh-Seng Tan, Shukui Qin, Kwang-Hyub Han, Brian Goh, Ho Seong Han, Junji Furuse, Xu Zhu, Joanna Zhi Jie Ling, Mihir Gandhi Background: HCC is the 6th most common cancer worldwide with > 70% of cases in Asia.

Differences in presentation and management patterns in patients with hepatocellular carcinoma (HCC) between China and Singapore: Initial data from the HCC Registry in Asia. Pierce K. H. Chow, Lequn Li, Jiangtao Li, Poh-Seng Tan, Fan Jia, Shukui Qin, Yvanka Marie Gilliam, Joanna Zhi Jie Ling, Mihir Gandhi Background: HCC is the 6th most common cancer in the world with > 70% of cases in

APAC Overview of the Accelerated Approval Pathways- Applications in LUNG Cancer Johnson I1, Chou B1, Grillo V2, Sevilla M2, Singh SS2, Gilliam Y21Amgen, JAPAC, Hong Kong, Hong Kong, 2Kantar, Singapore, Singapore OBJECTIVES: Speeding up the delivery of drugs that treat serious diseases helps ensure timely access to important therapeutic interventions. The aim of this review is to provide

166P Differences and similarities in presentation and management patterns in patients with hepatocellular carcinoma (HCC) across Hong Kong, Singapore and Thailand Background An estimated 841,000 new Hepatocellular Carcinoma (HCC) cases have been identified globally, with Asia having the highest incidence (73%). However, there is limited real world data on how HCC is diagnosed and on

166P – Differences and similarities in presentation and management patterns in patients with hepatocellular carcinoma (HCC) across Hong Kong, Singapore and Thailand.

Potential patient leakage from under-diagnosis of EGFR exon20 insertions in non-small cell lung cancer based on real-world testing behavior in Japan and Korea.